Cargando…

Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients

OBJECTIVE: The predictors of Fanconi syndrome (FS) accompanied by renal function decline with use of the antiretroviral tenofovir disoproxil fumarate (TDF) have not been assessed. In addition, the natural history of renal recovery from FS after TDF discontinuation is not well-described. DESIGN: We p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Samir K., Anderson, Albert M., Ebrahimi, Ramin, Fralich, Todd, Graham, Hiba, Scharen-Guivel, Valeska, Flaherty, John F., Fortin, Claude, Kalayjian, Robert C., Rachlis, Anita, Wyatt, Christina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961428/
https://www.ncbi.nlm.nih.gov/pubmed/24651857
http://dx.doi.org/10.1371/journal.pone.0092717
_version_ 1782308302343897088
author Gupta, Samir K.
Anderson, Albert M.
Ebrahimi, Ramin
Fralich, Todd
Graham, Hiba
Scharen-Guivel, Valeska
Flaherty, John F.
Fortin, Claude
Kalayjian, Robert C.
Rachlis, Anita
Wyatt, Christina M.
author_facet Gupta, Samir K.
Anderson, Albert M.
Ebrahimi, Ramin
Fralich, Todd
Graham, Hiba
Scharen-Guivel, Valeska
Flaherty, John F.
Fortin, Claude
Kalayjian, Robert C.
Rachlis, Anita
Wyatt, Christina M.
author_sort Gupta, Samir K.
collection PubMed
description OBJECTIVE: The predictors of Fanconi syndrome (FS) accompanied by renal function decline with use of the antiretroviral tenofovir disoproxil fumarate (TDF) have not been assessed. In addition, the natural history of renal recovery from FS after TDF discontinuation is not well-described. DESIGN: We prospectively enrolled HIV-infected patients receiving TDF with newly identified FS (defined as at least two markers of proximal tubulopathy and either a >25% decline in creatinine clearance (CrCl) from pre-TDF values or a CrCl <60 mL/min in those without a known pre-TDF CrCl) in a multicenter observational study. These case participants were matched 1∶2 to controls; characteristics between the two groups were compared. Case participants with known pre-TDF CrCl values were then followed over 48 weeks to assess renal recovery. RESULTS: Nineteen cases and 37 controls were enrolled. In multivariable analysis, previous or concurrent use of lopinavir/ritonavir [OR 16.37, 95% CI (2.28, 117.68); P = 0.006] and reduced creatinine clearance prior to initiation of TDF [OR 1.44 for every 5 mL/min reduction, 95% CI (1.09, 1.92); P = 0.012; OR 19.77 for pre-TDF CrCl lower than 83 mL/min, 95% CI (2.24, 174.67); P = 0.007] were significantly associated with FS. Of the 14 cases followed for resolution, 7 (50%) achieved at least partial resolution (defined as recovering CrCl >70% of pre-TDF values) although most participants had full normalization of proximal tubulopathy markers within two months of TDF discontinuation. CONCLUSIONS: FS, defined by specific CrCl decreases and markers of tubulopathy, is more likely in those who have received or are currently receiving concomitant lopinavir/ritonavir or who had lower CrCl prior to TDF initiation. Half of those with protocol-defined FS had CrCl recover to near pre-TDF values during the first year after TDF discontinuation.
format Online
Article
Text
id pubmed-3961428
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39614282014-03-24 Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients Gupta, Samir K. Anderson, Albert M. Ebrahimi, Ramin Fralich, Todd Graham, Hiba Scharen-Guivel, Valeska Flaherty, John F. Fortin, Claude Kalayjian, Robert C. Rachlis, Anita Wyatt, Christina M. PLoS One Research Article OBJECTIVE: The predictors of Fanconi syndrome (FS) accompanied by renal function decline with use of the antiretroviral tenofovir disoproxil fumarate (TDF) have not been assessed. In addition, the natural history of renal recovery from FS after TDF discontinuation is not well-described. DESIGN: We prospectively enrolled HIV-infected patients receiving TDF with newly identified FS (defined as at least two markers of proximal tubulopathy and either a >25% decline in creatinine clearance (CrCl) from pre-TDF values or a CrCl <60 mL/min in those without a known pre-TDF CrCl) in a multicenter observational study. These case participants were matched 1∶2 to controls; characteristics between the two groups were compared. Case participants with known pre-TDF CrCl values were then followed over 48 weeks to assess renal recovery. RESULTS: Nineteen cases and 37 controls were enrolled. In multivariable analysis, previous or concurrent use of lopinavir/ritonavir [OR 16.37, 95% CI (2.28, 117.68); P = 0.006] and reduced creatinine clearance prior to initiation of TDF [OR 1.44 for every 5 mL/min reduction, 95% CI (1.09, 1.92); P = 0.012; OR 19.77 for pre-TDF CrCl lower than 83 mL/min, 95% CI (2.24, 174.67); P = 0.007] were significantly associated with FS. Of the 14 cases followed for resolution, 7 (50%) achieved at least partial resolution (defined as recovering CrCl >70% of pre-TDF values) although most participants had full normalization of proximal tubulopathy markers within two months of TDF discontinuation. CONCLUSIONS: FS, defined by specific CrCl decreases and markers of tubulopathy, is more likely in those who have received or are currently receiving concomitant lopinavir/ritonavir or who had lower CrCl prior to TDF initiation. Half of those with protocol-defined FS had CrCl recover to near pre-TDF values during the first year after TDF discontinuation. Public Library of Science 2014-03-20 /pmc/articles/PMC3961428/ /pubmed/24651857 http://dx.doi.org/10.1371/journal.pone.0092717 Text en © 2014 Gupta et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gupta, Samir K.
Anderson, Albert M.
Ebrahimi, Ramin
Fralich, Todd
Graham, Hiba
Scharen-Guivel, Valeska
Flaherty, John F.
Fortin, Claude
Kalayjian, Robert C.
Rachlis, Anita
Wyatt, Christina M.
Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients
title Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients
title_full Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients
title_fullStr Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients
title_full_unstemmed Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients
title_short Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients
title_sort fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in hiv-infected patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961428/
https://www.ncbi.nlm.nih.gov/pubmed/24651857
http://dx.doi.org/10.1371/journal.pone.0092717
work_keys_str_mv AT guptasamirk fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT andersonalbertm fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT ebrahimiramin fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT fralichtodd fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT grahamhiba fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT scharenguivelvaleska fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT flahertyjohnf fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT fortinclaude fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT kalayjianrobertc fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT rachlisanita fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients
AT wyattchristinam fanconisyndromeaccompaniedbyrenalfunctiondeclinewithtenofovirdisoproxilfumarateaprospectivecasecontrolstudyofpredictorsandresolutioninhivinfectedpatients